JBCH – J B Chemicals and Pharmaceuticals Ltd
🔒
- Healthcare
- National Stock Exchange of India
- June 12, 2023
Subscribe for full access
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $3.99/month
Recommendation Rating
1.77
1
2
3
4
5
1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL
#VALUE!
Total Analysts: 13
Company Profile
J. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). It is involved in the provision of product development services. The Company offers varied products and dosage forms across therapeutic categories, which includes gastroenterology, hypertension, dermatology, nephrology, respiratory, virology, diabetes, wound care, anti-infectives, pharmacovigilance and nicotine replacement therapy (NRT). Its offers lozenges, which includes center-filled, soft-centered lozenges, center-filled, powder lozenges, herbal lozenges, and medicated lozenges. Its APIs products include Diclofenac Sodium, Diclofenac Diethylamine, Diclofenac Acid, Diclofenac Potassium, Nifedipine, Atenolol, Cilnidipine, and Ciprofloxacin HCl. The Company also owns Razel (Rousvastatin) franchise for the India and Nepal.
We do our best to screen stocks as accurately as possible. Please let us know in the Community if you spot an error or find something questionable. Jazaak Allahu khairan.